Early research (Phase 1)Study completedNCT02788188
What this trial is testing
Safety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy Adults
Who this might be right for
Middle East Respiratory Syndrome Coronavirus
National Institute of Allergy and Infectious Diseases (NIAID) 38